AI Terminal
Assura PLC
Report Publication Announcement • Mar 9, 2021
4924_rns_2021-03-09_aed6d4a2-a5bc-46f9-9d4a-293ae0e1e999.html
Report Publication Announcement
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 5539R
Assura PLC
09 March 2021
9 March 2021
Assura plc
Investor Presentation
Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, is pleased to announce that Jonathan Murphy (CEO) and Jayne Cottam (CFO) will host a live company update presentation via the Investor Meet Company platform on Thursday 18th March at 2pm.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and register to follow Assura plc via this link: https://www.investormeetcompany.com/assura-plc/register-investor
Investors who already follow Assura plc on the Investor Meet Company platform will automatically be invited to the event.
- ENDS -
For more information, please contact:
| Assura plc David Purcell, Head of Investor Relations |
Tel: 01925 420660 Email: [email protected] |
| Finsbury Gordon Simpson James Thompson |
Tel: 0207 251 3801 Email: [email protected] |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCUWSWRANUORAR